- 全部删除
 您的购物车当前为空 您的购物车当前为空
SB-633825 can inhibit cancer cell growth and angiogenesis. SB-633825 is an effective and ATP-competitive inhibitor of TIE2, LOK, and BRK (IC50s: 3.5 nM, 66 nM, 150 nM, respectively).


为众多的药物研发团队赋能,
让新药发现更简单!
SB-633825 can inhibit cancer cell growth and angiogenesis. SB-633825 is an effective and ATP-competitive inhibitor of TIE2, LOK, and BRK (IC50s: 3.5 nM, 66 nM, 150 nM, respectively).
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 2 mg | ¥ 1,370 | 5日内发货 | |
| 5 mg | ¥ 3,320 | 5日内发货 | |
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,530 | 5日内发货 | 
SB-633825 相关产品
| 产品描述 | SB-633825 can inhibit cancer cell growth and angiogenesis. SB-633825 is an effective and ATP-competitive inhibitor of TIE2, LOK, and BRK (IC50s: 3.5 nM, 66 nM, 150 nM, respectively). | 
| 靶点活性 |  Brk:150 nM, Tie2:3.5 nM, LOK:66 nM | 
| 体外活性 | SB-633825 (0.1 μM) inhibits LOK to 44% maximal activity and TIE2 to 75% maximal activity. SB-633825 inhibits TIE2 Tyrosine-protein kinase, lymphocyte-oriented kinase (LOK; STK10), and breast tumor kinase (Brk; PTK6) [1]. | 
| 分子量 | 483.58 | 
| 分子式 | C28H25N3O3S | 
| CAS No. | 956613-01-7 | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容